** Shares of medical device maker NeuroOne Medical
Technologies Corp NMTC.O rise 4.68% to $1.79 premarket
** Co completes initial animal implant of its paddle leads
for spinal cord stimulation, intended to relieve chronic pain of
the back, arms and legs
** The veterinary surgeon reported no concerns regarding the
placement of the lead in the sheep model
** These results demonstrate feasibility for placement of a
thin film paddle lead to treat chronic back pain due to multiple
failed back surgeries - NMTC
** Co is also developing a delivery system to insert the
paddle leads into the spine
** Stock down 10% in last 12 months
(Reporting by Aditya Samal)
((Aditya.Samal@thomsonreuters.com;))